Further purification was carried out by size-exclusion chromatography with a Superdex 75 gel permeation column (HiLoad 16/600, GE Healthcare) equilibrated in SEC buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0) at a flow rate of 1 ml/min. The purified protein was concentrated and adjusted to 10 mg/ml. The protein samples were kept at -20 °C until use. Protein concentration was determined by measuring the intensity of absorbance at 280 nm.
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Screening for Nascent Peroxidase Activity. 5 µL of the metal ion solution (2.5 mM, FeSO 4 , NiCl 2 , MnCl 2 , CuSO 4 , ZnCl 2 , CoSO 4 or VOSO 4 ) was added to a protein stock solution (0.5 mL, 20 µM) in 20 mM Tris-buffer at pH 8.0 containing 150 mM NaCl. Then, H 2 O 2 (7.5 µL, 100 mM) and o-dianisidine (5 µL, 25 mM) were added to initiate the oxidation reaction of o-dianisidine.
Crystallization of 6-PGLac (Apo-form without CuSO 4 ) and Cu·6-PGLac (6-PGLac with CuSO 4 ). Crystals of both forms were obtained by the sitting drop vapor diffusion method at 20 °C. Crystallization droplets were prepared by mixing the precipitant solution (0.2 µl) and protein solution (0.2 µl). 10 and 25 mg/ml solution were used for without and with CuSO 4 , respectively. Precipitant contains Mix A (20% polyethylene glycol 1000, 0.2 M Li 2 SO 4 , and 0.1 M phosphate/citrate (pH 4.2)) and Mix B (22.5% polyethylene glycol 4000, 15% glycerol, 150 mM (NH 4 ) 2 SO 4 , and 3 mM CuSO 4 ) for without and with CuSO 4 , respectively. Crystals of 6-PGLac were grown in 3 days and were cryoprotected in a reservoir solution supplemented with ethylene glycol in a stepwise fashion (ethylene glycol final concentration (v/v) of 10%, 15%, 20% and 25%, 5 min each) and directly transferred into liquid nitrogen. Crystals of Cu·6-PGLac were obtained in 4 days and were cryoprotected in a reservoir solution supplemented with 3 mM CuSO 4 and 20 mM Tris-HCl (pH 8.0) and 0.15 M NaCl, and ethylene glycol in a stepwise fashion (ethylene glycol final concentration (v/v) of 10%, 15%, 20% and 25%, 5 min each). The crystals were subsequently soaked into the same solutions with 12 mM CuSO 4 for 2h and directly transferred into liquid nitrogen to freeze them.
Data Collection of X-Ray Diffraction and Structure Determination. All diffraction data were collected at the PXI-Xo6SA and the PXIII-Xo6DA beamlines at the Swiss light source (SLS) synchrotron facility at the Paul Scherrer Institute (Villigen, Switzerland). X-ray diffraction images were collected on pilatus 2M and 6M detectors equipped with a cryo-system at 100 K using a wavelength of 1.0 Å. The data were processed and scaled with the XDS program package. The data collection and refinement statistics are summarized in Table S4 . The two crystal structures of 6-PGLac were solved by molecular replacement with Phaser using the model of the reported coordinate (PDB code: 3Q6C) as search model. The resulting model covered 243 residues of the one subunit in an asymmetric unit with 243 side chains assigned. The structure model was manually rebuilt with the program COOT 3 followed by refinement calculations with the program Phenix.refine. 4 This procedure was iterated until the model did not further improve. In the structures, Ramachandran analysis with the Molprobity program showed no outliers. 5 The final structure of 6-PGLac and Cu·6-PGLac contains residues Ala0-Leu244 and Ser2-Leu244 respectively. The electron density at the N-terminal Strep-tag II regions was too weak/absent to allow reliable building of residues Trp(-10)-Lys(-3). The missing residues and atoms are summarized in Table S5 . The anomalous difference Fourier maps were calculated from the data set of Cu·6-PGLac using the Phenix suite. All figures of protein structures were prepared using PyMOL (Version 1.3 Schrödinger, LLC).
Substrate Docking Simulation. The crystal structure coordinations of Cu·6-PGLac (PDB code: 4TM7) and o-dianisidine (PDB ligand entry: DDJ) were used in the substrate-protein docking studies. Hydrogens were added to the Cu·6-PGLac structures. The o-dianisidine was docked into cavity around Cu1 with GOLD Suite. All of the side chains were not allowed to rotate during docking and twenty dockings were visually inspected.
Kinetic Measurements. The kinetic experiments were performed in a 96-well plate reader (Infinite 200, TECAN). All measurements were conducted at room temperature (~ 25 °C). The reaction mixture was prepared by adding CuSO 4 (4.9 µL, 500 µM) and each reactant (H 2 O 2 (20 µL, 100 mM), t-butyl hydroperoxide (20 µL, 100 mM), ascorbate (7.5 µL, 100 mM), and glucose oxidase (6 µL, 1 µM) with glucose (7.5 µL, 2 M)) to protein solution (280 µL, 4 µM) in Tris-buffer (pH 8.0, 20 mM, 150 mM NaCl). For the other metal ions, solution of 500 µM FeSO 4 , NiCl 2 , MnCl 2 , CuSO 4 , ZnCl 2 , CoSO 4 or VOSO 4 were used instead of CuSO 4 . The reactions were initiated by adding the substrate solution (7.5 µL, 10 mM). The amount of product was calculated using ε 460 nm = 11. 3.3, 6.6, 10, 13, 17, 20 , 26 µL of 2.5 mM and 10, 13, 17, 25 µL of 10 mM). The amount of product was determined using the molar extinction coefficient at 460 nm ε 460 nm = 11.3 cm -1 ·mM -1 . 6, 7 The reaction velocity was calculated from the initial slope in triplicate. Steadystate kinetic parameters (catalytic turnover number (k cat ) and Michaelis constant (K M ) were determined by nonlinear fitting of Michaelis-Menten plots. The background reaction caused by free copper was subtracted from the raw data for fitting purposes (Fig. S12B) .
Detection of Native Lactonase Activity. The NMR experiments were recorded with a 600 MHz Bruker spectrometer. The detection of the lactonase activity was performed as described previously.
10 500 µL of a solution containing NADP + (3 mM), Glucose-6-phosphate (20 mM), MgCl 2 (5 mM) and CuSO 4 (12 µM) in TEA-buffer (pH 6.7, 1 M) was prepared for the first NMR experiment (t = 0 min). After 10 min a second NMR experiment was done (t = 10 min). Then Glucose-6-phosphate dehydrogenase (final concentration, 2 µM) was added and the NMR experiments were repeated (up to 20 min). Finally, 6-PGLac (final concentration, 3.5 µM) was added and another NMR experiments were measured (up to 45 min).
Electron Paramagnetic Resonance Spectroscopy. The EPR measurements at 9 GHz were performed with a JEOL JES-FA100 by using highly purified quartz tubes (I.D. 4.0 mm, Radical Research Inc.) with a rubber septum under an N 2 saturated conditions at 77 K. The microwave power and the modulation amplitude were 1 mW and 0.3 mT, respectively. 500 µM CuSO 4 was added into 1 mM (final) protein solution. The spectral simulation was carried out using a simulation software, JEOL AniSimu/FA ver 2.0.0. The simulation parameters are given in Fig.  S14C .
Fluorescence experiments. Fluorescence quenching measurements were performed at 20 °C with a JASCO FP-6300 according to the ref. 11 The excitation wavelength and spectral bandwidths were 290 nm and 5 nm, respectively. 6-PGLac (final concentration, 4.0 µM) was titrated with a concentrated solution of CuSO 4 (4 mM) After each addition, the resulting solution was equilibrated for 15 min before performing the fluorescence measurement. 
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Cu·6-PGLac (PDB: 4TM7)
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The yields of proteins 1, 2, 3, 4, 5, and 6 were about 42, 26, 11, 34, 16, 15 mg per L of medium, respectively. Subsequent purification of the proteins was performed by size-exclusion chromatography (SEC). During this purification step, protein 3 and 4 eluted as two peaks suggesting the possible existence of the two different tertiary structures. The arrows indicate the collected peaks. The homogeneity of isolated proteins was confirmed by SDS-PAGE. proteins used in this study. The determined masses are almost identical to calculated mass from the amino acid sequence without initial Met (Fig. S2) . o-quinone at 470 nm and 398 nm, respectively. Cu·6-PGLac does not catalyze the oxidation of guaiacol with either H 2 O 2 (6.6 mM, black) or t-BuOOH (6.6 mM, orange). In contrast, Cu·6-PGLac catalyses the peroxidation of catechol with H 2 O 2 (6.6 mM, blue) or t-BuOOH (6.6 mM, purple). However, the background peroxidation reaction of catechol with t-BuOOH is significant (compare green-and purple trace). Glucose-6-phosphate dehydrogenase (G6PDH, 12 min), new peaks appeared: i) an intense signal at 5.5 ppm and ii) a week signal at 5.55 ppm. These signals are assigned to δ-6-phosphogluconolactone and the γ-6-phosphogluconolactone, respectively (δ-6PGL and γ-6PGL).
A small signal is also apparent at 6.0 ppm. After 8 min, 6-PGLac was added. In a following spectrum, the peak of 6-phosphogluconate (6PGA, 6.0 ppm) increases rapidly. Accordingly the peaks of the δ-6PGL and γ-6PGL gradually decrease. These results demonstrate that 6-PGLac indeed converts 6-phosphogluconolactone into 6-phosphogluconate.
To investigate the effect of Cu 2+ ion its native activity, the experiment was repeated in the presence of 12 µM CuSO 4 in an NMR-tube. Under these conditions, the conversion from the 6-phosphogluconolactone to 6-phosphogluconate upon addition of 6-PGLac was still apparent. Close-up views of two fully occupied copper binding sites (green spheres). (C) Other unspecific bound copper binding sites (orange spheres). The crystal structure of 6-PGLac was determined by molecular replacement using the structure of the reported 6-phosphogluconolactonase (PDB code: 3OC6) as a search model. 6-PGLac (apo form) was crystallized with one monomer in the crystallographic asymmetric unit (space group I4 1 22) and the final structure was refined to a resolution of 1.81 Å with excellent statistics (Table S4 ). The protomer consists of 256 amino acid residues deduced from DNA sequence and MS analysis (Fig. S4F) and most of the residues were well defined in the final electron density, except for some disordered loops in the N-terminal flexible regions (mainly Strep-tag II, Table S5 ). The overall structure is nearly identical to the reported structure (PDB code: 3OC6, RMSD = 0.57 (243 Cα atoms)).
In the crystal co-crystallized with 3 mM CuSO 4 and then soaked with 12 mM CuSO 4 (Cu·6-PGLac), there is one monomer in the crystallographic asymmetric unit (space group P3 2 12). The final structure was refined to a resolution of 1.39 Å with excellent statistics. In this crystal structure, most of the residues were also well defined in the final electron density, except for some disordered loops in the N-terminal flexible regions (mainly Strep-tag II, Table S5 ) as it is the case with 6-PGLac. Three copper ions were identified by strong peaks in anomalous difference Fourier map contoured at 15 σ as threshold value including in the putative metal binding site. The alternative positions for copper binding (Cu2 and Cu3, 22 Å and 32 Å apart from Cu1) were observed in the crystal lattice contacts (Fig. S9B ). On the edge of the pseudo β-sheet structure, Cu2 was supported by carboxyl His9 and Asp3' (prime refers to residues from the adjacent protomer). Cu3 was also located on the interface between protomers in the different crystal lattice and supported by H95, Asp158' and Asp220'. Around Cu2, a tight inter-protomer interaction was observed. These two protomers are likely to be held together through 4-hydrogen bonds between Asp3-Arg8 forming an anti-parallel pseudo-β sheet structure on each other. Under physiological conditions, 6-PGLac was found to exist mainly as a monomer.
Detailed scrutiny of the anomalous difference Fourier map contoured at 3 σ as threshold value, 13 other copper binding sites were found on the protein surface including the lactonase active site (Cu7 , Table S6 and Fig S9C) . All of these copper ions were > 12 Å far from Cu1 and have much lower occupancies and higher isotropic B-factors (0.299 and 42.7 (average), respectively) as compared to those of the three copper binding sites described above (0.970 and 24.5 (average), respectively). The detailed B-factors of each copper are summarized in Table S6 . The determined masses are almost identical to the calculated masses derived from the corresponding amino acid sequence without the initial Met (Fig. S2) . 
